Bright Lifecare's prescription services spinout has secured $15m in series B funding, following a $6m Intel-backed round last year.

India-based drug prescription management platform 1mg has raised Rs 1bn ($15m) in series B funding, a year after it spun out of health and wellness e-commerce company Bright Lifecare, Business Standard reported on Wednesday.

The funding came from Sequoia India, the local branch of US-based venture capital firm Sequoia Capital, as well as hedge fund sponsor Maverick Capital Ventures and investment firm Omidiyar Network.

Spun out of Bright Lifecare in April 2015, 1mg operates a platform that provides prescription…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?